Atlas Trials

A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD

Clinical trial NCT02643082 · COMPLETED

Trial details

NCT number
NCT02643082
Sponsor
Pearl Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COPD
Start date
2015-12-23
Primary completion
2017-01-26
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.